Key Marijuana Executive Changes: Who Will Lead MariMed After CEO’s Passing? MJBiz CEO Steps Down
MJBiz CEO To Step Down
Marijuana Business Daily's Chris Walsh will step down as CEO in January.
MariMed Earnings Perspective: Return On Capital Employed
Benzinga Pro data, MariMed (OTC:MRMD) reported Q3 sales of $33.91 million. Earnings fell to a loss of $10.11…
MariMed’s Q3 Financial Results, Revenue Increases 3% Sequentially To $33.9M
MariMed, Inc. (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, recently announced its financial results for the third quarter that ended September 30, 2022.
Earnings Outlook For MariMed
MariMed (OTC:MRMD) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement.
Analysts estimate that MariMed will report an earnings per share (EPS) of $0.01.
Cannabis Stock Gainers And Losers From November 2, 2022
GAINERS:
LOSERS:
RIV Capital (OTC:CNPOF) shares closed down 12.25% at $0.30
Bearish Sentiment Across The Cannabis Space – Check Full Movers For October 21, 2022
GAINERS:
Cannabix Technologies (OTC:BLOZF) shares closed up 7.71% at $0.37
Cannabis Stock Movers For October 10, 2022
GAINERS:
Cipher Pharmaceuticals (OTC:CPHRF) shares closed up 74.81% at $2.29
Cannabis Stock Gainers And Losers From September 21, 2022
GAINERS:
Icanic Brands (OTC:ICNAF) shares closed up 18.62% at $0.07
Marijuana Stock Movers For September 19, 2022
GAINERS:
Icanic Brands (OTC:ICNAF) shares closed up 16.92% at $0.08